Partner Content Partner Content Overwhelmed with KOL Data Over the past few years there’s been a significant increase in the number of technology tools and platforms, our included, that Pharma is using to manage every step of the KOL engagement cycle - id
Partner Content Partner Content Summarising & Combining Insights Sometimes your MSLs may capture several insights that are very similar to each other in content and theme.
Views & Analysis Improving oncology KOL engagement Combining technology with human insights is a powerful tool in identifying and engaging effectively with oncology experts.
News GSK boosts anti-infectives pipeline with Scynexis antifungal Last year, GSK said it was planning to invest a cool £1 billion in infectious d
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?
